Associations between hormones, metabolic markers, and bone mass in perimenopausal and postmenopausal women
Journal of Bone and Mineral Metabolism · 2025
DOI: 10.1007/s00774-025-01595-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone and Mineral Metabolism, 2025. Verfasst von Bingru Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Rd, Huaiyin, Jinan, …. Hauptthemen laut MEDLINE: Perimenopause, Postmenopause, Biomarkers, Bone Density. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Introduction
To explore the associations between hormones, metabolic markers, and low bone mass in perimenopausal and postmenopausal women. Materials and methods A total of 198 women were enrolled in this study. The correlations between hormones, metabolic markers, and BMD were analyzed. Risk factors for bone loss were identified. Receiver operating characteristic (ROC) curves were used to display the predictive power of these risk factors.
Results
The years since menopause and the levels of glucose (GLU), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) were inversely correlated with BMD, while estrogen and testosterone were positively correlated with BMD. Age (odds ratio [OR] 1.232; 95% confidence interval [CI] 1.106–1.372; p < 0.001), GLU (OR 1.848; 95% CI 1.116–3.059; p = 0.017), and FSH (OR 1.089; 95% CI 1.003–1.182; p = 0.042) were identified as risk factors for bone loss. Age (AUC = 0.884, 95% CI 0.833–0.935), FSH (AUC = 0.824, 95% CI 0.760–0.888), and GLU (AUC = 0.683, 95% CI 0.599–0.768) demonstrated significant discrimination capability for bone loss. The combined application of these factors resulted in a better prediction effect (AUC = 0.930, 95% CI 0.893–0.967).
Conclusions
Age, FSH, and GLU were found to be specific risk factors for bone loss. The utilization of these factors offers compelling predictive power for bone loss in perimenopausal and postmenopausal women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Rd, Huaiyin, Jinan, 250021, Shandong, People's Republic of China.
- Department of Clinical Laboratory, Binzhou Central Hospital, Binzhou, 251700, Shandong Province, China.
- Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Rd, Huaiyin, Jinan, 250021, Shandong, People's Republic of China. yqliu1979@163.com.
Förderung
- Natural Science Foundation of Shandong Province
Zitieren
APA
Lu, B., Han, Q., Zhao, S., Ding, S., Bao, G., & Liu, Y. (2025). Associations between hormones, metabolic markers, and bone mass in perimenopausal and postmenopausal women. Journal of Bone and Mineral Metabolism. https://doi.org/10.1007/s00774-025-01595-x
Vancouver
Lu B, Han Q, Zhao S, Ding S, Bao G, Liu Y. Associations between hormones, metabolic markers, and bone mass in perimenopausal and postmenopausal women. Journal of Bone and Mineral Metabolism. 2025. doi:10.1007/s00774-025-01595-x
BibTeX
@article{Lu2025,
author = {Lu, Bingru and Han, Qunxiao and Zhao, Shiyu and Ding, Shan and Bao, Guolin and Liu, Yiqing},
title = {Associations between hormones, metabolic markers, and bone mass in perimenopausal and postmenopausal women},
journal = {Journal of Bone and Mineral Metabolism},
year = {2025},
doi = {10.1007/s00774-025-01595-x}
}
EUVIMED